Evaluation of class I HDAC isoform selectivity of largazole analogues

Abstract

Largazole is a potent class I selective histone deacetylase (HDAC) inhibitor. The majority of largazole analogues to date have modified the thiazole-thiazoline and the warhead moiety. In order to elucidate class I-specific structure–activity relationships, a series of analogues with modifications in the valine or the linker region were prepared and evaluated for their class I isoform selectivity. The inhibition profile showed that the C2 position of largazole has an optimal steric requirement for efficient HDAC inhibition and that substitution of the trans-alkene in the linker with an aromatic group results in complete loss of activity. This data will aid the design of class I isoform selective HDAC inhibitors.

Largazole Analogues as Histone Deacetylase Inhibitors and Anticancer Agents: An Overview of Structure–Activity Relationships

“…Recently, Luesch and co‐workers proposed largazole analogues with modified ZBGs connected to the macrocyclic core by both rigidified and flexible linkers . Compounds 7 – 9 , including either a phenyl or a triazole ring within the linker (Figure ) did not show any inhibitory activity against class I HDACs, suggesting that these modifications either prevented the ligands warheads to be properly placed within the enzyme channel containing the Zn 2+ ion or did not allow the formation of the ideal zinc‐thiolate coordination geometry.…”

Predicting the unpredictable: Recent structure–activity studies on peptide-based macrocycles

“…Hong and co-workers investigated the effect of stereochemical change on carbon 17 (C17) and a Valine-Alanine substitution in the macrocyclic backbone (L17 & 18, Table 10) [97]. Changing the stereochemistry on C17 to generate L17 completely eliminated the molecule's cytotoxicity.…”

The Search for Potent, Small‐Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat

“…in 2012 have synthesized a series of cyclic tetrapeptide 47a – d (Table ) with a potency comparable to that of the TSA (IC 50 = 4.1 nM) with IC 50 values between 4.3 and 8.2 nM for HDAC1 . The molecules 48a – j (Table ) showed to be very selective and potent with noticeable activity toward HDACs 1,2,3 but are not active against HDAC8 …”